thyroid hormone receptor β agonistsglucagon-like peptide 1 receptor agonistsfibroblast growth factor 21 analoguestype 2 diabetes mellitussteatohepatitissteatotic liver disease (SLD)metabolic dysfunction-associated steatotic liver disease (MASLD)Cirrhosishepatitis
…have been developed or approved for treatment of SLD, including thyroid hormone receptor β agonists, glucagon-like peptide 1 receptor agonists and fibroblast growt…